Literature DB >> 25152340

Special considerations for children with hyperhidrosis.

Benjamin R Bohaty1, Adelaide A Hebert2.   

Abstract

Hyperhidrosis, characterized by excess sweat production, affects children and adults. Primary focal hyperhidrosis affects any anatomic region with sweat appendages present. Primary hyperhidrosis has traditionally been considered a problem for adults, but approximately 1.6% of adolescents and 0.6% of prepubertal children are affected. Psychological and social development and well-being are often affected, leading to profound emotional and social distress. Quality of life can be improved by early diagnosis and therapy; however, underdiagnosis and lack of knowledge regarding therapeutic options has hindered optimization of therapy in the pediatric population. This article reviews the treatment options for hyperhidrosis with a focus on the pediatric population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; Hyperhidrosis; Iontophoresis; Pediatric population

Mesh:

Year:  2014        PMID: 25152340     DOI: 10.1016/j.det.2014.06.005

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  Over a decade of single-center experience with thoracoscopic sympathicolysis for primary palmar hyperhidrosis: a case series.

Authors:  Adam Mol; Oliver J Muensterer
Journal:  Surg Endosc       Date:  2020-07-08       Impact factor: 4.584

2.  A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.

Authors:  Dee Anna Glaser; David M Pariser; Adelaide A Hebert; Ian Landells; Chris Somogyi; Emily Weng; Mitchell F Brin; Frederick Beddingfield
Journal:  Pediatr Dermatol       Date:  2015-06-08       Impact factor: 1.588

3.  New trends in botulinum toxin use in dermatology.

Authors:  Stefania Guida; Francesca Farnetani; Steven P Nisticò; Caterina Giorgio Mariarosaria; Graziella Babino; Giovanni Pellacani; Elisabetta Fulgione
Journal:  Dermatol Pract Concept       Date:  2018-10-31

4.  Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.

Authors:  Adelaide A Hebert; Dee Anna Glaser; Lawrence Green; Cheryl Hull; Jennifer Cather; Janice Drew; Ramanan Gopalan; David M Pariser
Journal:  Pediatr Dermatol       Date:  2020-03-08       Impact factor: 1.588

5.  Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.

Authors:  Adelaide A Hebert; Dee Anna Glaser; Lawrence Green; William P Werschler; Douglass W Forsha; Janice Drew; Ramanan Gopalan; David M Pariser
Journal:  Pediatr Dermatol       Date:  2018-11-19       Impact factor: 1.588

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.